It was then pointed out to the Commission that the use of a single frequency does not close the case studies of use of RFID, that in certain fields of application (eg, that of medical supplies, liquids and metals) technology uses LF or HF (125 kHz or 13.56 MHz).
On the protection of the health of the operators and users, we held a special session in which they were presented several studies and research to ensure full biocompatibility of the devices.
During this session was presented a search of Prof. Franz Adlkofer, call REFLEX in which biological samples were exposed for 24 hours at a frequency of about 2 GHz to 2 watts of power (and therefore well above the frequencies and the values of power RFID).
The results showed that the values of genotoxicity (ie, the level of genetic errors during cell replications) of the samples were exposed to four times higher than normal. In order to clarify aspects of this research, we interviewed Professor Paul Ravazzani, a researcher at the Institute of Biomedical Engineering ISIB Milan Section of the CNR, present as a speaker at the workshop.
On the issues of RFID has opened a public consultation, available here, to allow everyone to provide insights to the European Commission. From the results obtained from the public consultation, you will get a final conference in Brussels on October 16.
The importance of participation in this consultation has been emphasized by the European Commissioner Viviane Reding.
|
